A Case of p-ANCA-Positive Propylthiouracil-Induced Pyoderma Gangrenosum
- PMID: 20548880
- PMCID: PMC2883396
- DOI: 10.5021/ad.2010.22.1.48
A Case of p-ANCA-Positive Propylthiouracil-Induced Pyoderma Gangrenosum
Abstract
Propylthiouracil is a common medication used in patients with hyperthyroidism; it can cause perinuclear antineutrophil cytoplasmic antibodies (p-ANCA) in some patients with Graves' disease. This antibody has been associated with various forms of vasculitis and neutrophilic dermatosis. Herein, we report a patient who presented with cutaneous manifestations of pyoderma gangrenosum with simultaneous development of p-ANCAs during PTU therapy for Graves' disease.
Keywords: Propylthiouracil; Pyoderma gangrenosum; p-ANCA.
Figures


Similar articles
-
[Neutrophilic dermatosis associated with propylthiouracil-induced p-ANCA (p-antineutrophil cytoplasmic antibodies)].Ann Dermatol Venereol. 2005 Jan;132(1):27-31. doi: 10.1016/s0151-9638(05)79191-2. Ann Dermatol Venereol. 2005. PMID: 15746603 French.
-
[Pyoderma gangrenosum associated with anti-proteinase 3 antineutrophil cytoplasmic antibodies (PR3-ANCA) induced by propylthiouracil].Ann Dermatol Venereol. 2017 May;144(5):368-373. doi: 10.1016/j.annder.2017.01.018. Epub 2017 Mar 11. Ann Dermatol Venereol. 2017. PMID: 28291538 French.
-
Prevalence of perinuclear antineutrophil cytoplasmic antibody in patients with Graves' disease treated with propylthiouracil or methimazole in Taiwan.J Formos Med Assoc. 2004 Apr;103(4):274-9. J Formos Med Assoc. 2004. PMID: 15175822
-
[Antineutrophil cytoplasmic antibody (Anca)-associated autoimmune disease induced by propylthiouracil].Arq Bras Endocrinol Metabol. 2007 Feb;51(1):136-41. doi: 10.1590/s0004-27302007000100022. Arq Bras Endocrinol Metabol. 2007. PMID: 17435868 Review. Portuguese.
-
Antineutrophil Cytoplasmic Antibody-Positive Small-Vessel Vasculitis Associated with Antithyroid Drug Therapy: How Significant Is the Clinical Problem?Thyroid. 2015 Dec;25(12):1273-81. doi: 10.1089/thy.2014.0603. Epub 2015 Oct 19. Thyroid. 2015. PMID: 26414658 Review.
Cited by
-
Evaluation of neutrophil extracellular trap deregulated formation in pyoderma gangrenosum.Exp Dermatol. 2021 Sep;30(9):1340-1344. doi: 10.1111/exd.14397. Epub 2021 May 31. Exp Dermatol. 2021. PMID: 34057268 Free PMC article.
-
Neutrophilic Dermatoses in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A French Multicenter Study of 17 Cases and Literature Review.Medicine (Baltimore). 2016 Mar;95(11):e2957. doi: 10.1097/MD.0000000000002957. Medicine (Baltimore). 2016. PMID: 26986103 Free PMC article.
-
Propylthiouracil-Induced Vasculitis With Alveolar Hemorrhage Confirmed by Clinical, Laboratory, Computed Tomography, and Bronchoscopy Findings: A Case Report and Literature Review.Iran Red Crescent Med J. 2016 Feb 1;18(4):e23320. doi: 10.5812/ircmj.23320. eCollection 2016 Apr. Iran Red Crescent Med J. 2016. PMID: 27257510 Free PMC article.
References
-
- Darben T, Savige J, Prentice R, Paspaliaris B, Chick J. Pyoderma gangrenosum with secondary pyarthrosis following propylthiouracil. Australas J Dermatol. 1999;40:144–146. - PubMed
-
- Miller RM, Darben TA, Nedwich J, Savige J. Propylthiouracil-induced antineutrophil cytoplasmic antibodies in a patient with Graves' disease and a neutrophilic dermatosis. Br J Dermatol. 1999;141:943–944. - PubMed
-
- Hong SB, Lee MH. A case of propylthiouracil-induced pyoderma gangrenosum associated with antineutrophil cytoplasmic antibody. Dermatology. 2004;208:339–341. - PubMed
-
- Gungor K, Gonen S, Kisakol G, Dikbas O, Kaya A. ANCA positive propylthiouracil induced pyoderma gangrenosum. J Endocrinol Invest. 2006;29:575–576. - PubMed
-
- Jacobs EM, Hartkamp A, Kaasjager HA. PTU-associated cutaneous vasculitis with ANCA anti-MPO and anti-PR3 antibodies. Neth J Med. 2003;61:296–299. - PubMed
Publication types
LinkOut - more resources
Full Text Sources